A Trial to Evaluate Safety, Tolerability and Efficacy of Elamipretide in Subjects With Barth Syndrome

NCT03098797 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Barth Syndrome

Interventions

DRUG: Elamipretide
DRUG: Placebo

Sponsor

Stealth BioTherapeutics Inc.